Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Ontrak, Inc.
  6. News
  7. Summary
    OTRK   US6833731044

ONTRAK, INC.

(OTRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Ontrak : B. Riley Lowers Ontrak's PT to $58 from $73 on Lower Estimates, Keeps Buy Rating

05/10/2021 | 09:04am EDT


© MT Newswires 2021
All news about ONTRAK, INC.
07/22ONTRAK : to Report 2021 Second Quarter Financial Results on August 5, 2021
BU
07/07ONTRAK : Landmark Behavioral Health Study Presented at AHIP Event
BU
06/21ONTRAK, INC.(NASDAQGM : OTRK) dropped from S&P Health Care Services Select Indus..
CI
05/20ONTRAK : Optima Health Selects Ontrak for all Medicare and Medicaid Business
BU
05/20Optima Health Selects Ontrak for All Medicare and Medicaid Business
CI
05/11ONTRAK : to Present at the 2021 RBC Capital Markets Global Healthcare Conference
BU
05/10ONTRAK : B. Riley Lowers Ontrak's PT to $58 from $73 on Lower Estimates, Keeps B..
MT
05/06ONTRAK : Earnings Flash (OTRK) ONTRAK Posts Q1 Revenue $28.7M, vs. Street Est of..
MT
05/06ONTRAK : Earnings Flash (OTRK) ONTRAK Reports Q1 Loss $-0.17, vs. Street Est of ..
MT
05/06ONTRAK, INC. : Results of Operations and Financial Condition, Financial Statemen..
AQ
More news
Financials (USD)
Sales 2021 84,2 M - -
Net income 2021 -41,5 M - -
Net Debt 2021 - - -
P/E ratio 2021 -12,2x
Yield 2021 -
Capitalization 496 M 496 M -
Capi. / Sales 2021 5,89x
Capi. / Sales 2022 4,04x
Nbr of Employees 724
Free-Float 45,0%
Chart ONTRAK, INC.
Duration : Period :
Ontrak, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ONTRAK, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 26,68 $
Average target price 40,86 $
Spread / Average Target 53,1%
EPS Revisions
Managers and Directors
Jonathan E. Mayhew Chief Executive Officer
Curt Medeiros President & Chief Operating Officer
Brandon H. LaVerne Chief Financial Officer
Terren S. Peizer Executive Chairman
Julia Wright Chief Medical Officer
Sector and Competitors